// App-Quantinova.ai

POS0052 (2022) : ANGIOGENIC T CELLS AS RELEVANT PLAYERS IN THE LUNG VASCULOPATHY OF RHEUMATOID ARTHRITIS, SYSTEMIC SCLEROSIS AND OTHER AUTOIMMUNE DISEASES

Researchers

Presenter

  • V. Pulito-Cueto

Principal Investigators

  • S. Remuzgo-Martnez

  • F. Genre

  • B. Atienza-Mateo

  • V. Portilla

  • V. M. Mora-Cuesta

  • D. Iturbe Fernndez

  • L. Lera-Gomez

  • J. Rodriguez Carrio

  • D. Prieto-Pea

  • R. Blanco

  • A. Corrales

  • O. Gualillo

  • J. M. Cifrin-Martnez

  • R. Lpez-Mejas

  • M. A. Gonzlez-Gay

Medical Centers

  • IDIVAL, Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, Santander, Spain

  • Hospital Universitario Marqués de Valdecilla. IDIVAL., Rheumatology and Ophthalmology, Santander, Spain

  • Hospital Universitario Marqués de Valdecilla, Santander, Spain, Department of Immunology, Santander, Spain

  • Universidad de Oviedo, Department of Functional Biology, Immunology Area, Faculty of Medicine, Oviedo, Spain

  • Laboratorio Investigacion and Rheumatology Unit, Instituto Investigacion Sanitaria- Hospital Clinico Universitario de Santiago, Santiago de Compostela, Spain

  • Universidad de Cantabria, School of Medicine, Santander, Spain

  • Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla;, Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain

  • University of the Witwatersrand, Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, Johannesburg, South Africa

Locations

  • Spain

  • South Africa

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

  • Rheumatoid arthritis

  • Scleroderma

  • Pulmonary fibrosis

  • Inflammatory Arthritis

Biomarkers

  • Cluster of Differentiation 2AP

  • Cluster of Differentiation 31

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I

Study Id's

  • N/A

Sponsors

  •  European Regional Development Fund (ERDF)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved